Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review
about
Brain tumors in Sweden: data from a population-based registry 1999-2012.Transcriptional changes induced by bevacizumab combination therapy in responding and non-responding recurrent glioblastoma patientsImpairments in Quality of Life and Cognitive Functions in Long-term Survivors of Glioblastoma.Deferred use of bevacizumab for recurrent glioblastoma is not associated with diminished efficacy.Correlation of altered expression of the autophagy marker LC3B with poor prognosis in astrocytoma.Prognostic significance of astrocyte elevated gene-1 in human astrocytomasmiRNAs expression analysis in paired fresh/frozen and dissected formalin fixed and paraffin embedded glioblastoma using real-time pCR.The impact of bevacizumab treatment on survival and quality of life in newly diagnosed glioblastoma patients.Definition of miRNAs expression profile in glioblastoma samples: the relevance of non-neoplastic brain reference.Long-term survival of patients suffering from glioblastoma multiforme treated with tumor-treating fields.The Childhood Cancer Survivor Study-Neurocognitive Questionnaire (CCSS-NCQ) revised: item response analysis and concurrent validityAssessing the quality of life among caregivers of patients with gliomas.Characterization of a Raman spectroscopy probe system for intraoperative brain tissue classification.Lessons from anti-vascular endothelial growth factor and anti-vascular endothelial growth factor receptor trials in patients with glioblastoma.Successful Treatment of Intracranial Glioblastoma Xenografts With a Monoamine Oxidase B-Activated Pro-Drug.Orexin A suppresses the growth of rat C6 glioma cells via a caspase-dependent mechanism.The effects of anti-angiogenic therapy on the formation of radiation-induced microbleeds in normal brain tissue of patients with glioma.Cerebral Blood Flow Changes in Glioblastoma Patients Undergoing Bevacizumab Treatment Are Seen in Both Tumor and Normal Brain.Neurocognitive Changes Associated With Surgical Resection of Left and Right Temporal Lobe GliomaDistribution of polymer nanoparticles by convection-enhanced delivery to brain tumors.Anticancer activity of β-Elemene and its synthetic analogs in human malignant brain tumor cells.Cost-effectiveness analysis of the bevacizumab-irinotecan regimen in the treatment of primary glioblastoma multiforme recurrences.Investigating the impact of headaches on the quality of life of patients with glioblastoma multiforme: a qualitative study.Selective anti-tumor activity of the novel fluoropyrimidine polymer F10 towards G48a orthotopic GBM tumors.Neurocognitive functioning and genetic variation in patients with primary brain tumours.Changes in neurocognitive functioning and quality of life in adult patients with brain tumors treated with radiotherapy.Factors influencing quality of life in adult patients with primary brain tumors.Bevacizumab-based therapy in relapsed glioblastoma: rationale and clinical experience to date.Living longer with adult high-grade glioma: setting a research agenda for patients and their caregivers.Patient reported endpoints for measuring clinical benefit in (high grade glioma) primary brain tumor patients.Neurocognitive functions and health-related quality of life in glioblastoma patients: a concise review of the literature.Interleukin-1-induced changes in the glioblastoma secretome suggest its role in tumor progression.Betulinic acid derivatives NVX-207 and B10 for treatment of glioblastoma--an in vitro study of cytotoxicity and radiosensitization.Romo1 is associated with ROS production and cellular growth in human gliomas.Synergy of enediyne antibiotic lidamycin and temozolomide in suppressing glioma growth with potentiated apoptosis induction.Mechanism of temozolomide-induced antitumour effects on glioma cells.Prospective evaluation of health-related quality of life in patients with glioblastoma multiforme treated on a phase II trial of hypofractionated IMRT with temozolomide.Illness intrusiveness and subjective well-being in patients with glioblastoma.Overexpression of vascular adhesion protein-1 is associated with poor prognosis of astrocytomas.Development and validation of a prognostic model for recurrent glioblastoma patients treated with bevacizumab and irinotecan.
P2860
Q30868551-B39577AF-7154-4EC3-9E3D-0CF33B219F25Q33576750-01825CCB-B2CE-4226-B0F3-CE43A214855AQ33594936-26ADF78E-702B-495A-AE3E-5E8215334607Q33616632-277A605D-7F3C-4583-B619-6D02CC64DB44Q33678281-0AC932EE-AF63-4814-BC2C-628A35847116Q34121490-ED1F9892-B31B-4DA2-87FC-46A7347343ADQ34243937-DD1D6E81-0338-4741-99FF-713A58A5D515Q34293163-2FB2E60D-FE9D-4B01-A6A7-8AD1688FF2A7Q34576376-B00B0A05-C4D2-4F25-A179-F6693EFDC559Q34644506-9D17D2F9-80E8-4134-B437-C8EE64152666Q34714835-2304A2AE-9CF2-4053-B6BE-69E301073B9BQ35206278-21DA94C3-A456-4857-AB69-77389F6B5B1AQ35707719-3A31590C-A718-4517-8FA1-19CB9FD6150AQ35895174-38BA1595-22F6-452A-BBB3-F85535384BCCQ36106198-17A26439-34F6-4992-8DC3-7548CF941B3BQ36247741-02DA8A73-64EA-4616-AE13-51825D78F83EQ36367405-4559DC2D-290B-42AD-AFC3-AF43DBBCFD89Q36589758-C2342635-6B44-4054-9C7B-0E7092EF52B6Q36797235-BCCAFE57-4356-44F2-BBBE-FB46068AEE71Q36971160-B280872F-0786-463D-A704-52D1738B33F5Q37080487-3D652E1E-D310-466F-B20B-1D01755790D9Q37204582-42DB6238-0DA4-40C7-949F-BB107D36272FQ37454496-264264B1-1E7D-4510-8BCC-A15910D59E1EQ37526280-1C236A4D-5671-4FE1-8BF1-73747B3D9AF7Q37561807-66DA77A0-26A8-4564-AD89-0FD14C7A53D2Q37987088-E06449A5-F6C2-48BD-9424-16A15F049BF1Q38055319-0370F4C8-409E-4559-BEA9-221262C650E0Q38068203-779910E6-ED60-46DD-B8C8-03353930F070Q38224780-E04BFADE-A38C-48C7-8923-0CB7C0003CF5Q38244843-40F7FD86-DD3A-464F-B01F-E16FF0D32DA1Q38623875-0F08317F-CD6C-49FC-A5AB-019A350CFDD3Q38637324-67314B05-4572-401C-B9FB-28C87BC4BAFDQ38943486-887B3380-388E-4F6E-8467-7C6A9EB800FBQ38959431-E7BD4A6A-5E1C-4372-A6A3-8906BF252438Q38993557-FAF88788-B34A-484C-9F29-F008D4186B64Q39044642-631AE2E5-EE12-4ED5-B9D9-39FEFF48F1A1Q39408928-E3C8ECFD-5664-4203-8596-AFA262A56370Q40485578-807C0D24-EAE8-4EF6-84B8-D63C140687EBQ40875907-B5899E8D-8DF7-4F4F-BB57-33A124D672C0Q40939911-9937C76C-55F5-496B-A492-33EFDA514829
P2860
Impact of therapy on quality of life, neurocognitive function and their correlates in glioblastoma multiforme: a review
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 06 April 2011
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Impact of therapy on quality o ...... oblastoma multiforme: a review
@en
Impact of therapy on quality o ...... blastoma multiforme: a review.
@nl
type
label
Impact of therapy on quality o ...... oblastoma multiforme: a review
@en
Impact of therapy on quality o ...... blastoma multiforme: a review.
@nl
prefLabel
Impact of therapy on quality o ...... oblastoma multiforme: a review
@en
Impact of therapy on quality o ...... blastoma multiforme: a review.
@nl
P2093
P2860
P921
P1476
Impact of therapy on quality o ...... oblastoma multiforme: a review
@en
P2093
Hans Skovgaard Poulsen
Roger Henriksson
Thomas Asklund
P2860
P2888
P304
P356
10.1007/S11060-011-0565-X
P577
2011-04-06T00:00:00Z
2011-09-01T00:00:00Z